Clinical Trials Directory

Trials / Unknown

UnknownNCT01057849

Standard Comprehensive Intervention to Treat First-episode Schizophrenia

Sequenced Atypical Antipsychotics Therapy With Intensive or Basic Psychosocial Intervention for First-episode Schizophrenia: An Effectiveness Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
Peking University · Academic / Other
Sex
All
Age
16 Years – 45 Years
Healthy volunteers
Accepted

Summary

Schizophrenia is not a curable but a treatable disease by antipsychotics. Kinds of atypical antipsychotics are widely used since 1990s' in China. Although their efficacy for acute phase are all better than typicals, individulized regimen of them for first-episode schizophrenia and their effectiveness in real naturalistic clinical settings still remain unclear. And those patients also need more comprehensive intervention such as psychosocial programs to improve their function. This protocol is to conduct a study in several sites of China to investigate the effectiveness of comprehensive intervention combining sequenced atypical antipsychotic therapy and intensive psychosocial intervention for first-episode schizophrenic patients. In addition, this protocol also aims at collecting such information as molecular genetics, neurochemical test, neucognitive performance and neuroimaging for outcome analysis.

Conditions

Interventions

TypeNameDescription
DRUGrisperidone3-6 mg per day
DRUGolanzapine5-20 mg per day
DRUGAripiprazole10-30 mg per day

Timeline

Start date
2008-09-01
Primary completion
2011-03-01
First posted
2010-01-27
Last updated
2010-01-27

Locations

6 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01057849. Inclusion in this directory is not an endorsement.